Posted by Merritt Engel · December 13, 2019 10:01 AM
Read more
Share
Posted by Merritt Engel · December 06, 2019 7:00 AM
Read more
Share
Posted by Merritt Engel · November 01, 2019 10:53 AM
BioCryst launches Phase 1 trial for FOP
Read more
Share
Posted by Merritt Engel · October 16, 2019 11:01 AM
Ipsen and Blueprint enter exclusive agreement in FOP
Read more
Share
Posted by Merritt Engel · September 20, 2019 2:53 PM
11 FOP Presentations Will Be Made At The Annual Meeting
Read more
Share
Posted by Merritt Engel · August 28, 2019 2:49 PM
Learn how research on RAR gamma agonists motivated the Palovarotene clinical trials
Read more
Share
Posted by Merritt Engel · August 28, 2019 2:48 PM
Read more
Share
Posted by Merritt Engel · May 31, 2019 4:58 PM
Blueprint Medicines conducting a one-time research study and looking for volunteers
Read more
Share
Posted by Merritt Engel · May 24, 2019 10:43 AM
Posted on behalf of the Clinical Trials Committee of the International Clinical Council on FOP (ICC)
Read more
Share
Posted by Merritt Engel · March 11, 2019 2:56 PM
The 2019 edition of the FOP Treatment Guidelines is now available
Read more
Share
